Tulane spin-out company to develop new treatment for pelvic organ prolapse

The Tulane spin-out BioAesthetics is teaming up with a Tulane biomedical engineering professor to develop a new graft for treating pelvic organ prolapse, which affects millions of women around the world.

BioAesthetics, whose CEO and COO are both Tulane graduates, is collaborating with Tulane researcher Kristin Miller, an associate professor of biomedical engineering whose lab will conduct the testing of the graft.